NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

Flipper is right on this one.

The AMRN IP was obviously a huge concern and any investor should have know it. Not saying the Courts had to go the wrong way for them, but it was clear and present danger.

Ranting about it being "lawless" is nonsense. Patent law is full of issues where something may or may not obvious. Given that everybody knew that a mix of EPA and DHA provided cardio benefits it might be obvious that one or the other did in some specific indication.

BTW, I do think AMRN is being screwed on the off label use issue by generics. But that is another issue.AMRN can start suing patients and docs for this, but that obviously will end up badly.